EV/EBITDA
-0.47
0.000.00%
Thu, 06 Mar 2025 00:39:10 GMT
Summary
- As of March 6, 2025, VYNE EV/EBITDA is -0.47, unchanged from the previous trading day.
- Over the past year, VYNE EV/EBITDA has dropped by -0.43 (-1075.00%).
- VYNE EV/EBITDA is now -157.32% below its all-time high of 0.82.
Performance
VYNE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VYNE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | +6.0% | -5.9% | -3.2% |
| 3 m3 months | +24.2% | -24.9% | -14.7% |
| 6 m6 months | -1040.0% | +1319.2% | +20.3% |
| ytdytd | +41.3% | -42.1% | -27.5% |
| 1 y1 year | -1075.0% | +1233.7% | +1.6% |
| 5 y5 years | +50.0% | -75.4% | -99.2% |
VYNE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.66 | +28.8% | |
| 3 m | 3-month | -0.47 | at high | -1.25 | +62.4% |
| 6 m | 6-month | 0.15 | -413.3% | -1.25 | +62.4% |
| 1 y | 1-year | 0.19 | -347.4% | -1.25 | +62.4% |
| 3 y | 3-year | 0.82 | -157.3% | -1.41 | +66.7% |
| 5 y | 5-year | 0.82 | -157.3% | -3.86 | +87.8% |
| alltime | all time | 0.82 | -157.3% | -29.03 | +98.4% |
VYNE Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.47(-41.3%) |
| 2024 | -0.80(+900.0%) |
| 2023 | -0.08(-112.1%) |
| 2022 | 0.66(-300.0%) |
| Date | Value |
|---|---|
| 2021 | -0.33(-67.0%) |
| 2020 | -1.00(-45.7%) |
| 2019 | -1.84(+20.3%) |
| 2018 | -1.53 |
FAQ
- What is VYNE Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for VYNE Therapeutics?
- What is VYNE EV/EBITDA year-to-date change?
- What is VYNE Therapeutics EV/EBITDA year-on-year change?
What is VYNE Therapeutics EV/EBITDA?
The current EV/EBITDA of VYNE is -0.47
What is the all time high EV/EBITDA for VYNE Therapeutics?
VYNE Therapeutics all-time high EV/EBITDA is 0.82
What is VYNE EV/EBITDA year-to-date change?
VYNE Therapeutics EV/EBITDA has changed by +0.33 (+41.25%) since the beginning of the year
What is VYNE Therapeutics EV/EBITDA year-on-year change?
Over the past year, VYNE EV/EBITDA has changed by -0.43 (-1075.00%)